Exploring the Role of Magnesium in Rest Cramps

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study sets out to show whether infusions of magnesium can lessen the frequency of rest cramps and to determine whether rest cramp sufferers have a deficiency in magnesium.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of the Myofascial Trigger Point Injections on Pain and Sleep Disturbance in Patients With Nocturnal Leg Cramps With Trigger Points on Gastrocnemius Muscle

NCT01804556

Nocturnal Leg Cramps

COMPLETED NA

Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome

NCT04732507

Myofascial Pain Myofascial Trigger Point Pain

ENROLLING_BY_INVITATION PHASE2

Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia

NCT00928564

Pelvic Floor Muscle Spasm

COMPLETED NA

Magnesium Sulphate Injection in Treatment of Myofascial Trigger Points

NCT04742140

Trigger Point Pain, Myofascial

COMPLETED PHASE4

Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients

NCT01520415

Low Back Pain

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will be randomized to receive 5 days of 4 hour IV infusions of D5W either with or without 20 mmol magnesium sulfate added. Twenty four hour urinary excretion of magnesium will be determined on the first day of infusions to assess whether magnesium deficiency is present. Ten normal controls will also undergo a single infusion and collection of urine to serve as a comparison group for the urinary excretion data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rest Cramps

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intravenous Infusion of Magnesium Sulfate

See Detailed Description.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥2 leg or foot cramps per week in a 4 week run-in diary

Exclusion Criteria

* eGFR\<50
* Neurologic disease
* Pregnancy
* Heart block
* Bradyarhythmia without pacemaker
* Digoxin use
* Liver disease
* Addison's disease
* History of MI
* CHF
* Absence of detectable reflexes

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes